90 related articles for article (PubMed ID: 25234436)
1. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N
Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study.
Li N; Li Z; Fu Q; Zhang B; Zhang J; Wan XB; Lu CM; Wang JB; Deng WY; Ma YJ; Bie LY; Wang MY; Li J; Xia QX; Wei C; Luo SX
Int J Surg; 2024 Apr; 110(4):2071-2084. PubMed ID: 38320099
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer.
Yokota T; Kato K; Hamamoto Y; Tsubosa Y; Ogawa H; Ito Y; Hara H; Ura T; Kojima T; Chin K; Hironaka S; Kii T; Kojima Y; Akutsu Y; Matsushita H; Kawakami K; Mori K; Nagai Y; Asami C; Kitagawa Y
Br J Cancer; 2016 Nov; 115(11):1328-1334. PubMed ID: 27811857
[TBL] [Abstract][Full Text] [Related]
4. NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU+Lenograstim) Followed by Chemoradiation Based 5FU and Oxaliplatin and Surgery.
Mineur L; Plat F; Desseigne F; Deplanque G; Belkacemi M; Moureau-Zabotto L; Beyrne CD; Jalali K; Obled S; Smith D; Vazquez L; Boustany R
Cancer Res Treat; 2024 Apr; 56(2):580-589. PubMed ID: 37817565
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
Zhao Y; Li D; Zhuang J; Li Z; Xia Q; Li Z; Yu J; Wang J; Zhang Y; Li K; Xu S; Li S; Ma P; Cao Y; Liu C; Xu C; Liu Z; Wei J; Zhang C; Qiao L; Gao X; Hou Z; Liu C; Zheng R; Wang D; Liu Y
Clin Transl Med; 2024 May; 14(5):e1674. PubMed ID: 38685486
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
Schuhmacher C; Gretschel S; Lordick F; Reichardt P; Hohenberger W; Eisenberger CF; Haag C; Mauer ME; Hasan B; Welch J; Ott K; Hoelscher A; Schneider PM; Bechstein W; Wilke H; Lutz MP; Nordlinger B; Van Cutsem E; Siewert JR; Schlag PM
J Clin Oncol; 2010 Dec; 28(35):5210-8. PubMed ID: 21060024
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial.
Wei J; Lu X; Liu Q; Fu Y; Liu S; Zhao Y; Zhou J; Chen H; Wang M; Li L; Yang J; Liu F; Zheng L; Yin H; Yang Y; Zhou C; Zeng P; Zhou X; Ding N; Chen S; Zhao X; Yan J; Fan X; Guan W; Liu B
Nat Commun; 2023 Aug; 14(1):4904. PubMed ID: 37580320
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neoadjuvant versus upfront surgery for treatment of locally advanced gastric cancer.
Omarov N; Uymaz DS; Gurbuz B; Selcukbiricik F; Cigtaskin O; Yesilsoy M; Ozoran E; Balik E; Bugra D
Ann Ital Chir; 2023; 94():569-579. PubMed ID: 37724662
[TBL] [Abstract][Full Text] [Related]
9. A Phase II Study of Neoadjuvant Chemoradiotherapy with Docetaxel, Cisplatin and 5-FU Followed by Surgical Resection in the Treatment of Locally Advanced Esophagogastric Junction Cancer and Locally Advanced Esophageal Cancer.
Chen CC; Yeh HL; Chuang CY; Hsu CP
Clin Pract; 2024 Apr; 14(2):642-652. PubMed ID: 38666809
[TBL] [Abstract][Full Text] [Related]
10. Multicentre phase II pharmacokinetic and pharmacodynamic study of OSI-7904L in previously untreated patients with advanced gastric or gastroesophageal junction adenocarcinoma.
Falk S; Anthoney A; Eatock M; Van Cutsem E; Chick J; Glen H; Valle JW; Drolet DW; Albert D; Ferry D; Ajani J
Br J Cancer; 2006 Aug; 95(4):450-6. PubMed ID: 16880795
[TBL] [Abstract][Full Text] [Related]
11. First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.
Tomasello G; Valeri N; Ghidini M; Smyth EC; Liguigli W; Toppo L; Mattioli R; Curti A; Hahne JC; Negri FM; Panni S; Ratti M; Lazzarelli S; Gerevini F; Colombi C; Panni A; Rovatti M; Treccani L; Martinotti M; Passalacqua R
Oncotarget; 2017 Dec; 8(67):111795-111806. PubMed ID: 29340092
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15-Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network.
Tankel J; Ahmed N; Mueller C; Najmeh S; Spicer J; Mulder D; Cool-Lartigue J; Rousseau M; Frechette D; Sud S; Kavan P; Moghrabi A; Champagne M; Lemay F; Dalfen R; Sirhan S; Asselah J; Alcindor T; Ferri L
Ann Surg Oncol; 2024 Apr; 31(4):2461-2469. PubMed ID: 38142255
[TBL] [Abstract][Full Text] [Related]
13. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma.
Shi JM; Li N; Jiang LM; Yang L; Wang SL; Song YW; Liu YP; Fang H; Lu NN; Qi SN; Chen B; Li YX; Zhao DB; Tang Y; Jin J
Sci Rep; 2024 Mar; 14(1):7522. PubMed ID: 38553594
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.
Pérez-Wert P; Custodio A; Jimenez-Fonseca P; Carmona-Bayonas A; Lecumberri A; Cacho Lavin D; Losantos García I; Fernández Montes A; Cano JM; Limón ML; Hernández San Gil R; Diez M; Vidal Tocino R; Macías Declara I; Visa L; Pimentel Cáceres P; Gil Raga M; Martínez Moreno E; Sauri T; Martín Richard M; Granja M; Cerdà P; Gómez González L; Mérida-García A; Ruiz Martín M; Gallego J;
Gastric Cancer; 2024 Jan; 27(1):131-145. PubMed ID: 37964032
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study.
Chen JY; Huang NS; Wei WJ; Hu JQ; Cao YM; Shen Q; Lu ZW; Wang YL; Wang Y; Ji QH
Ann Surg Oncol; 2023 Nov; 30(12):7172-7180. PubMed ID: 37543550
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study.
Sewastjanow-Silva M; Xiao L; Gonzalez GN; Wang X; Hofstetter W; Swisher S; Mehran R; Sepesi B; Bhutani MS; Weston B; Coronel E; Waters RE; Rogers JE; Smith J; Lyons L; Reilly N; Yao JC; Ajani JA; Murphy MB
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611056
[TBL] [Abstract][Full Text] [Related]
17. Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up.
Stelmach R; Apostolidis L; Kahle S; Sisic L; Nienhüser H; Weber TF; Jäger D; Haag GM
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14785-14796. PubMed ID: 37589924
[TBL] [Abstract][Full Text] [Related]
18. Expression of concern: "Patient-derived organoids from locally advanced gastric adenocarcinomas can predict resistance to neoadjuvant chemotherapy" [J Gastrointest Surg. 2023 Apr;27(4):666-76].
J Gastrointest Surg; 2024 Jun; 28(6):1008. PubMed ID: 38839209
[No Abstract] [Full Text] [Related]
19. Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer.
Soto M; Filbert EL; Yang H; Starzinski S; Starzinski A; Gin M; Chen B; Le P; Li T; Bol B; Cheung A; Zhang L; Hsu FJ; Ko A; Fong L; Keenan BP
Cancer Res Commun; 2024 Jan; 4(1):200-212. PubMed ID: 38181044
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
Hojo Y; Ishida Y; Tomita T; Kurahashi Y; Nakamura T; Kitayama Y; Nakao E; Kohno S; Murakami M; Takeuchi J; Takagawa T; Hirota S; Shinohara H
Eur J Surg Oncol; 2024 Feb; 50(2):107314. PubMed ID: 38101115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
